Research graph
References from Survival benefit of recurrence-focused treatment after surgery for pancreatic ductal adenocarcinoma: A propensity score matched analysis of patients from a Dutch National and US institutional cohort. Local targets link to admitted publications; unresolved targets remain external evidence.
Cancer statistics, 2024
2024 · External reference
Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial
10.1001/jama.2010.1275 · 2010 · External reference
Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical Trial
10.1001/jamaoncol.2022.3829 · 2022 · External reference
Patterns, timing, and predictors of recurrence following pancreatectomy for pancreatic ductal adenocarcinoma
10.1097/sla.0000000000002234 · 2018 · External reference
Multimodality treatment of recurrent pancreatic cancer: Mith or reality?
10.4251/wjgo.v7.i12.375 · 2015 · External reference
Detection, Treatment, and Survival of Pancreatic Cancer Recurrence in the Netherlands: A Nationwide Analysis
10.1097/sla.0000000000004093 · 2022 · External reference
A nationwide randomized controlled trial on additional treatment for isolated local pancreatic cancer recurrence using stereotactic body radiation therapy (ARCADE)
10.1186/s13063-022-06829-1 · 2022 · External reference
Re-resection for isolated local recurrence of pancreatic cancer is feasible, safe, and associated with encouraging survival
10.1245/s10434-012-2762-z · 2013 · External reference
Systematic review on the treatment of isolated local recurrence of pancreatic cancer after surgery; re-resection, chemoradiotherapy and SBRT
10.1016/j.hpb.2016.11.001 · 2017 · External reference
clinicalguidelines@esmo.org EGCEa: ESMO Clinical Practice Guideline Express Update on the management of metastatic pancreatic cancer
10.1016/j.esmoop.2025.104528 · 2025 · External reference
Pancreatic Adenocarcinoma, Version 1
2024 · External reference
Diagnosis and management of pancreatic cancer in adults: A summary of guidelines from the UK National Institute for Health and Care Excellence
10.1016/j.pan.2018.09.012 · 2018 · External reference
Progression of Site-specific Recurrence of Pancreatic Cancer and Implications for Treatment
10.1097/sla.0000000000006142 · 2024 · External reference
Predictive factors of FOLFIRINOX chemotherapy toxicity in pancreatic adenocarcinoma patients
2025 · External reference
FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer
10.1056/nejmoa1011923 · 2011 · External reference
Meta-analysis of recurrence pattern after resection for pancreatic cancer
10.1002/bjs.11295 · 2019 · External reference
Predicting post-recurrence survival for patients with pancreatic cancer recurrence after primary resection: A Bi-institutional validated risk classification
10.1016/j.ejso.2023.04.009 · 2023 · External reference
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
10.1016/j.jclinepi.2007.11.008 · 2008 · External reference
An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
10.1080/00273171.2011.568786 · 2011 · External reference
Regression Modeling Strategies
2015 · External reference
Recurrence in Patients Achieving Pathological Complete Response After Neoadjuvant Treatment for Advanced Pancreatic Cancer
10.1097/sla.0000000000003570 · 2021 · External reference
Routine Imaging or Symptomatic Follow-Up After Resection of Pancreatic Adenocarcinoma
2024 · External reference
Isolated pulmonary recurrence after resection of pancreatic cancer: the effect of patient factors and treatment modalities on survival
10.1016/j.hpb.2018.12.002 · 2019 · External reference
Routine Imaging After Resection of Pancreatic Ductal Adenocarcinoma: Nationwide Utilization and Survival Analysis
10.1097/sla.0000000000006772 · 2025 · External reference
Unresolved reference
2019 · External reference
Recurrent disease detection after resection of pancreatic ductal adenocarcinoma using a recurrence-focused surveillance strategy (RADAR-PANC): protocol of an international randomized controlled trial according to the Trials within Cohorts design
10.1186/s13063-024-08223-5 · 2024 · External reference
Routine Surveillance for Cancer Metastases - Does It Help or Harm Patients?
10.1056/nejmp2414159 · 2025 · External reference
Resection of Recurrent Pancreatic Cancer: Who Can Benefit?
10.1159/000519754 · 2022 · External reference
Impact of Different Primary Treatment Strategies on Recurrence-Focused Treatment of Pancreatic Ductal Adenocarcinoma
10.1245/s10434-025-18639-1 · 2026 · External reference
Launch of the PANC-PALS Consortium
10.1016/s2468-1253(24)00346-7 · 2024 · External reference
Patterns of disease relapse and posttreatment follow-up of patients with resected pancreatic adenocarcinoma: A single-center analysis
10.1002/jso.26985 · 2022 · External reference
Follow-up after curative surgery for pancreatic ductal adenocarcinoma: asymptomatic recurrence is associated with improved survival
10.1016/j.ejso.2013.02.020 · 2013 · External reference
Yield of clinical and radiographic surveillance in patients with resected pancreatic adenocarcinoma following multimodal therapy
10.1111/j.1477-2574.2012.00445.x · 2012 · External reference
Clinical Impact of Structured Post-Operative Surveillance in Resected Pancreatic Adenocarcinoma: Results from a Retrospective Cohort Study
10.1159/000528722 · 2023 · External reference
Trends Over Time in Recurrence Patterns and Survival Outcomes after Neoadjuvant Therapy and Surgery for Pancreatic Cancer
2024 · External reference
Delayed Versus Immediate Start of Chemotherapy in Asymptomatic Patients With Advanced Cancer: A Meta-Analysis
10.1093/oncolo/oyad235 · 2023 · External reference
Timing of start of systemic treatment in patients with asymptomatic metastasized pancreatic cancer (TIMEPAN): a protocol of a multicenter prospective patient preference non-randomized trial
10.1080/0284186x.2023.2273898 · 2023 · External reference
Quality of Life in Patients with Pancreatic Cancer-A Literature Review
10.3390/ijerph20064895 · 2023 · External reference
Quality of life among patients with locally advanced pancreatic cancer: a prospective nationwide multicenter study
10.6004/jnccn.2024.7091 · 2025 · External reference
Impact of FOLFIRINOX compared with gemcitabine on quality of life in patients with metastatic pancreatic cancer: results from the PRODIGE 4/ACCORD 11 randomized trial
10.1200/jco.2012.44.4869 · 2013 · External reference
Quality of life of patients with metastatic pancreatic adenocarcinoma initiating first-line chemotherapy in routine practice
10.1186/s12904-020-00610-4 · 2020 · External reference
